Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels.

Authors: Uno, S; Dalton, T P; Shertzer, H G; Genter, M B; Warshawsky, D; Talaska, G; Nebert, D W

Published In Biochem Biophys Res Commun, (2001 Dec 21)

Abstract: Previous studies have shown that cytochrome P450 1A1 (CYP1A1), CYP1B1, and prostaglandin-endoperoxide synthase (PTGS2) are inducible by benzo[a]pyrene (BaP) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin), and all three metabolize BaP to reactive DNA-binding intermediates and excreted products. Because these three enzymes show differing patterns of basal levels, inducibility, and tissue-specific expression, animal studies are necessary to delineate the role of CYP1A1 in BaP-mediated toxicity. In mice receiving large daily doses of BaP (500 mg/kg i.p.), Cyp1a1(-/-) knockout mice are protected by surviving longer than Cyp1a1(+/-) heterozygotes. We found that a single 500 mg/kg dose of BaP induces hepatic CYP1A1 mRNA, protein, and enzyme activity in Cyp1a1(+/-) but not in Cyp1a1(-/-) mice; TCDD pretreatment increases further the CYP1A1 in Cyp1a1(+/-) but not Cyp1a1(-/-) mice. Although a single 500 mg/kg dose of BaP was toxic to Cyp1a1(+/-) mice (serum liver enzyme elevated about 2-fold above control levels at 48 h), Cyp1a1(-/-) mice displayed no hepatotoxicity. Unexpectedly, we found 4-fold higher BaP-DNA adduct levels in Cyp1a1(-/-) than in Cyp1a1(+/-) mice; TCDD pretreatment lowered the levels of BaP-DNA adducts in both genotypes, suggesting the involvement of other TCDD-inducible detoxification enzymes. BaP was cleared from the blood much faster in Cyp1a1(+/-) than Cyp1a1(-/-) mice. Our results suggest that absence of the CYP1A1 enzyme protects the intact animal from BaP-mediated liver toxicity and death, by decreasing the formation of large amounts of toxic metabolites, whereas much slower metabolic clearance of BaP in Cyp1a1(-/-) mice leads to greater formation of BaP-DNA adducts.

PubMed ID: 11741297 Exiting the NIEHS site

MeSH Terms: Animals; Aryl Hydrocarbon Hydroxylases*; Benzo(a)pyrene/administration & dosage; Benzo(a)pyrene/metabolism*; Benzo(a)pyrene/pharmacokinetics; Benzo(a)pyrene/toxicity*; Carcinogens, Environmental/administration & dosage; Carcinogens, Environmental/pharmacokinetics; Carcinogens, Environmental/toxicity*; Cytochrome P-450 CYP1A1/deficiency*; Cytochrome P-450 CYP1A1/genetics*; Cytochrome P-450 CYP1A1/metabolism; Cytochrome P-450 CYP1B1; DNA Adducts/metabolism*; Liver/drug effects*; Liver/metabolism*; Mice; Mice, Knockout; Models, Biological; RNA, Messenger/biosynthesis; RNA, Messenger/genetics

to Top